All In MedTech

FDA Clearance Tracker · K233666

CorVista System with PH Add-On

A 510(k) clearance means FDA found the device substantially equivalent to one already on the market. It is not an approval, and it is not a finding that the device works better than others.

Last checked: Nov 20, 2026Latest source record: Apr 5, 2024 (this decision)Source: openFDAMethods & limitations

510(k)First of its product codeBreakthrough

Decided

Apr 5, 2024

Substantially Equivalent

Time to decision

142 days

Received Nov 15, 2023. Calendar days, including time FDA spent waiting on the applicant.

Pathway

510(k)

Traditional

Device class

Class II

The decision

FDA number
K233666
Device name
CorVista System with PH Add-On
Applicant location
Toronto, CA
Received
Nov 15, 2023
Decided
Apr 5, 2024
Decision
Substantially Equivalent
Submission type
Traditional

Device type

Device class
Class II
Regulation
21 CFR 870.2380

Every decision under product code SAT

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • This is the earliest decision in FDA's data under product code SAT (Pulmonary Hypertension Machine Learning-Based Notification Software).
  • It is on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026).

Source documents

The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.

Other decisions for Analytics For Life, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.